Sage Journals: Discover world-class research

Abstract

Objectives:

To quantify the impact of IV pump relocation for COVID-19 patients from the bedside to outside the patient room on nurse exposure to COVID-19 and conservation of PPE.

Design:

Original Article

Setting:

Intensive care units at a single-center teaching hospital.

Patients:

Critically ill COVID-19 patients under contact and special droplet precautions.

Interventions:

Relocation of intravenous pumps for COVID-19 patients from bedside to outside the patient room using extension tubing.

Measurements and Main Results:

The primary objective of the study was to measure the impact of this strategy on COVID-19 exposure, utilizing the number of nurse entries into the patient room as a surrogate endpoint, and extrapolation of this data to determine the reduction or PPE usage. Secondary endpoints included incidence of extravasation, hyperglycemia, hypotension, and diagnosis of CLABSI/bacteremia. A statistically significant reduction in the primary endpoint of the study was observed as room entries prior to pump relocation averaged 15.36 (± 4.10) as opposed to an average of 7.92 (± 2.19) following pump relocation (p < 0.0001). In both pre- and post-pump relocation groups, there was no incidence of extravasation or CLABSI. No significant differences were noted in number of patients experiencing hyperglycemia, hypotensive episodes, or bacteremia.

Conclusions:

There was a significant decrease in COVID-19 exposure based on the number of nurse entries following the relocation of intravenous pumps from inside to outside of the patient room. These results may be cautiously extrapolated to suggest a decrease in personal protective equipment utilization. Future prospective, randomized controlled trials investigating the impact of this strategy are required.

Keywords

coronavirus COVID-19 infusion pumps relocation personal protective equipment (PPE)

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention (CDC). COVID-19: Strategies to optimize the supply of PPE and equipment. Accessed April 21, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html

Hahn

. Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical products. Accessed May 1, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-further-steps-help-mitigate-supply-interruptions-food-and

U.S. Food & Drug Administration (US FDA). Surgical mask and gown conservation strategies - letter to health care providers. Accessed May 1, 2020. https://www.fda.gov/medical-devices/letters-health-care-providers/surgical-mask-and-gown-conservation-strategies-letter-health-care-providers

Shah

Taduran

Friedman

, et al. Relocating intravenous pumps for COVID-19 patients from bedside to outside the patient room. Crit Care Explor. 2020;2(8):e0168.

Institute for Safe Medication Practices (ISMP). Clinical experiences keeping infusion pumps outside the room for COVID-19 patients. ISMP Med Saf Alert Acute Care. 2019;25(6). Accessed May 1, 2020. https://ismp.org/resources/clinical-experiences-keeping-infusion-pumps-outside-room-covid-19-patients

U.S. Food & Drug Administration (US FDA). Enforcement policy for infusion pumps and accessories during the coronavirus disease 2019 (COVID-19) public health emergency. Accessed May 1, 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-infusion-pumps-and-accessories-during-coronavirus-disease-2019-covid-19-public

Sparnon

Cohen

, et al. Managing Infusion Therapies in the Age of COVID-19. Emergency Care Research Institute (ECRI). Accessed May 1, 2020. //www.ecri.org/landing-covid-infusion-therapy

Emergency Care Research Institute (ECRI). Large-volume infusion pumps-considerations when used with long extension sets outside patient rooms to help reduce staff PPE Use. Accessed May 1, 2020. https://assets.ecri.org/PDF/COVID-19-Resource-Center/COVID-19-Clinical-Care/COVID-Alert-Large-Vol-Infusion-Pumps.pdf

Dube

Jacob

Zheng

, et al. Comparison of rates of central line–associated bloodstream infections in patients with 1 vs 2 central venous catheters. JAMA Netw Open. 2020;3(3):e200396.

10.

Callister

Limchaiyawat

Eells

, et al. Risk factors for central line-associated bloodstream infections in the era of prevention bundles. Infect Control Hosp Epidemiol. 2015;36(2):214–216.

11.

Blake

JWC

Giuliano

. Flow accuracy of IV smart pumps outside of patient rooms during COVID-19. AACN Adv Crit Care. 2020;31(4):357–363.

Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients From Bedside to Outside the Patient Room